RECRUITING

Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology

Conditions

Gastrointestinal Cancer Remote Resistance Exercise GI Cancer Stage III GI Cancer Stage IV Tele-Resistance Training

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to evaluate a tele-resistance training exercise program for individuals undergoing chemotherapy for advanced upper gastrointestinal cancer.

Official Title

Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology (Remote REPS - GI)

Quick Facts

Study Start:2023-02-20

Study Completion:2025-02-28

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05664178

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Age ≥ 18 years * Biopsy-proven upper GI cancer, stage III-IV * ECOG performance status 0-1 * Treatment plan of chemotherapy with planned return to Moffitt Cancer Center for restaging * Able to read and speak English fluently * Capable of providing informed consent	* Regular engagement in RT (2x/week targeting all major muscle groups) * Screen failure for exercise safety based on Physical Activity Readiness Questionnaire (PAR-Q) and Patient-Reported Measurement Information System (PROMIS) screening questions * Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease (New York Heart Association functional class III or IV). * Recent fracture or acute musculoskeletal injury that precludes ability to participate in RT * Numeric pain rating scale of ≥ 7 out of 10 * Myopathic or rheumatologic disease that impacts physical function

Inclusion Criteria

Exclusion Criteria

* Age ≥ 18 years
* Biopsy-proven upper GI cancer, stage III-IV
* ECOG performance status 0-1
* Treatment plan of chemotherapy with planned return to Moffitt Cancer Center for restaging
* Able to read and speak English fluently
* Capable of providing informed consent

* Regular engagement in RT (2x/week targeting all major muscle groups)
* Screen failure for exercise safety based on Physical Activity Readiness Questionnaire (PAR-Q) and Patient-Reported Measurement Information System (PROMIS) screening questions
* Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease (New York Heart Association functional class III or IV).
* Recent fracture or acute musculoskeletal injury that precludes ability to participate in RT
* Numeric pain rating scale of ≥ 7 out of 10
* Myopathic or rheumatologic disease that impacts physical function

Contacts and Locations

Study Contact

Nathan Parker, PhD, MPH

CONTACT

813-745-0527

Nathan.Parker@moffitt.org

Principal Investigator

Nathan Parker, PhD, MPH

PRINCIPAL_INVESTIGATOR

Moffitt Cancer Center

Study Locations (Sites)

Moffitt Cancer Center

Tampa, Florida, 33612

United States

Collaborators and Investigators

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Nathan Parker, PhD, MPH, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-20

Study Completion Date2025-02-28

Study Record Updates

Study Start Date2023-02-20

Study Completion Date2025-02-28

Terms related to this study

Keywords Provided by Researchers

Gastrointestinal Cancer
Remote Resistance Exercise
GI Cancer Stage III
GI Cancer Stage IV
Tele-Resistance Training

Additional Relevant MeSH Terms

Gastrointestinal Cancer